Finland Fimea · July 13, 2026

EMA recommends withdrawal of marketing authorisation for Tavneos in the EU

Original title: EMA suosittelee Tavneos-valmisteen myyntiluvan peruuttamista EU:ssa

The EMA recommends the withdrawal of the marketing authorisation for Tavneos in the European Union.

Low obligation Product class Pharmaceuticals Finland Pharmaceuticals
Read the official source ↗

Published by Finland Fimea. HealthSignal links to the original document; the summary above is extracted from the source text.